CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.
CVS Health names Ed DeVaney president of PBM business
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS Caremark taps Ed DeVaney as president of PBM business
DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim president in December 2024, he will report to Prem Shah, group president of CVS Health.
CVS taps Ed DeVaney to head Caremark
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to manage increased medical costs. David Joyner, who previously led Caremark, was named CVS president and CEO in October, replacing previous chief executive Karen Lynch.
CVS Health names DeVaney as President of CVS Caremark
CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president
CVS names PBM president
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS Health.
Capital Rx on Breaking PBM Status Quo: Vanguards of Health Care
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
WVXU6h
Senate approves 'aggressive' reforms for pharmacy benefit managers to lower drug prices
Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Legislation looks to help with drug costs, provide transparency in pharmacy market
New federal legislation would regulate an industry that’s been examined by FactFinder. Senator Jerry Moran, R-Kan., is one of the sponsors of the bipartisan bill addressing drug costs and transparency ...
devdiscourse1d
Trump's High-Stakes Meeting with Big Pharma: A Game-Changer for Drug Pricing?
President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...
The Journal News7d
Congress must take on Pharmacy Benefit Manager Reform. It's a bipartisan win | Opinion
If you’ve ever walked out of a pharmacy without your needed prescription, a Pharmacy Benefit Manager is likely to blame. And everything they do is in the dark. There is little accountability or ...
'Incomplete picture': Prescription benefit manager pushes to dismiss lawsuit over 22-year-old's asthma death after inhaler price jump
The company blamed for the death of a young Wisconsin man who died from an asthma attack after his medication price rose from ...